Kodiak sciences inc. (KOD)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-24,392

-15,616

-12,380

-11,385

-7,984

-14,662

-10,452

-7,409

-8,920

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

120

133

145

130

130

123

123

122

122

Non-cash interest expense and amortization of debt discount and issuance cost

-

-

-

-

-

187

1,962

1,870

1,463

Change in fair value of redeemable convertible preferred stock warrant liability

-

-

-

-

-

0

995

80

1,625

Change in fair value of derivative instrument

-

-

-

-

-

74

1,150

438

326

Stock-based compensation

6,082

1,936

1,773

1,244

1,157

1,116

800

657

92

Amortization (accretion) of premium (discount) on marketable securities

125

46

77

100

18

-

-

-

-

Amortization of operating lease right-of-use asset

98

-

-

-

90

-

-

-

-

Amortization of issuance costs

9

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Prepaid expenses and other current assets

133

1,950

-1,934

135

17

1,492

238

175

90

Operating lease right-of-use asset

-

-

-

-

-

-

0

0

0

Other assets

1,602

146

306

4,059

0

-

-

-

-

Accounts payable

1,887

949

-722

748

594

-569

91

-462

-1,383

Accrued and other current liabilities

228

3,452

1,939

655

-1,114

1,406

574

417

-4,502

Operating lease liability

-104

-102

-96

-140

-45

-

-

-

-

Other liabilities

-

-

-

-

-

-2

11

14

8

Net cash used in operating activities

-17,932

-11,293

-7,696

-12,950

-7,207

-8,340

-4,984

-4,448

-11,259

Cash flows from investing activities
Purchase of property and equipment

180

153

158

119

7

22

18

38

0

Purchase of available-for-sale securities

-

-

-

-

-

-

0

0

0

Purchase of marketable securities

86,317

-

-

-

23,865

-

-

-

-

Maturities of marketable securities

19,300

-

-

-

-

-

-

-

-

Net cash used in investing activities

-67,197

-113,283

-523

680

-23,872

-525

-18

-38

0

Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

-

-

-

-

-

83,706

49

0

0

Proceeds from issuance of common stock upon options exercise

159

-

-

-

83

-

-

-

-

Proceeds from sale of future royalties, net of issuance costs

99,643

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes (includes $9,560 and $8,000 from related parties for the years ended December 31, 2018 and 2017, respectively)

-

-

-

-

-

0

0

0

33,000

Deferred offering costs

-

-

-

-

-

-

1,047

635

133

Debt issuance cost

-

-

-

-

-

0

0

0

140

Principal payments of capital lease

5

7

7

7

27

27

27

27

27

Principal payments of tenant improvement allowance payable

9

-

-

-

9

-

-

-

-

Principal payments of tenant improvement allowance payable

-

-

-

-

-

-

-

24

23

Net cash provided by financing activities

99,788

299,340

285

15

47

85,529

-1,049

-686

32,677

Net increase (decrease) in cash, cash equivalents and restricted cash

14,659

174,764

-7,934

-12,255

-31,032

76,664

-6,051

-5,172

21,418

Supplemental disclosures of non-cash investing and financing information:
Operating lease right-of-use asset obtained in exchange for operating lease liability

-

-

-

-

2,163

-

-

-

-

Unpaid offering costs

-

-

-

-

-

-1,372

282

-394

1,689

Purchase of property and equipment under accounts payable

-

-

-

27

110

-

-

-

-

Derivative instrument related to convertible notes

-

-

-

-

-

0

0

0

6,603